NCT03987334 is a NA clinical trial of Virtual Reality Treatment in Neck Pain, sponsored by IRCCS San Raffaele.

Who is sponsoring NCT03987334?

NCT03987334 is sponsored by IRCCS San Raffaele.

What drugs are being tested in NCT03987334?

Interventions in NCT03987334: Virtual Reality Treatment, Control Group.

What condition does NCT03987334 study?

NCT03987334 studies Neck Pain, Chronic Pain, Whiplash.

Is NCT03987334 still recruiting?

NCT03987334 is currently recruiting now. Last updated 23 February 2026.

Last reviewed 2026-02-23 · How we verify

NCT03987334

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Virtual Reality Rehabilitation in Neck Pain Subjects

Recruiting now NA Last updated 23 February 2026

What this trial tests

NA trial testing Virtual Reality Treatment in Neck Pain in 72 participants. Currently enrolling.

Timeline

9 May 2019

Primary endpoint
31 March 2028

31 March 2028

Quick facts

Lead sponsor	IRCCS San Raffaele
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	72
Start date	9 May 2019
Primary completion	31 March 2028
Estimated completion	31 March 2028
Sites	1 location across Italy

Drugs / interventions tested

Virtual Reality Treatment
Control Group — full drug profile →

Conditions studied

Neck Pain — all drugs for Neck Pain →
Chronic Pain — all drugs for Chronic Pain →
Whiplash — all drugs for Whiplash →

Sponsor

IRCCS San Raffaele — full company profile →

Who can join

Adults 18 to 70, any sex, with Neck Pain or Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

VR-NECKPAIN is a two-arm, monocentric, single-blind, randomized controlled trial in Neck Pain patients. The entire treatment consist in 12 sessions, each during 45 minutes, twice a week for 6 consecutive weeks. Subjects will be evaluated ad baseline (T0) and after six weeks of rehabilitation (T1). There will also be a 3 months Follow-Up assessment (T2). The total duration of study participation for each subject will be approximately 19 weeks, including evaluation at T0, treatment and evaluation at T1 and T2. Individuals in the experimental group (VRT) will undergo a virtual reality-based sensorimotor rehabilitation. Control group (CT) subjects will undergo the same rehabilitation of VR subjects, in terms of intensity, time and type, but with the virtual reality turned off.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Sensory-motor training with virtual reality as a complementary intervention to manual therapy for persistent non-specific neck pain: a randomized controlled trial.
Emedoli D, Alemanno F, Iannaccone S, Houdayer E, et al · · 2024 · PMID 38922315 · DOI 10.23736/s1973-9087.24.08115-2

Verify or expand the search:

Other recruiting trials for Neck Pain

Currently open trials in the same condition.

NCT07163533 — Combined Effect of Kendall Exercises With Wearable Vibrotactile Feedback Sensor in Forward Head Posture · NA · recruiting
NCT07332845 — Symmetrical Scapula-pelvis Proprioceptive Neuromuscular Facilitation and Superficial Back Line in Chronic Neck Pain With · NA · recruiting
NCT07524075 — Effects of Muscle Energy Technique on Neck Disability and Cervical Range of Motion in Individuals With Non-Specific Neck · NA · recruiting
NCT07292350 — Investigation of the Effects of a Neuromuscular Control-Focused Posture Training Program in Butchers · NA · recruiting
NCT07290361 — Stratified Targeted Engagement From Primary Care to Physical Therapy (STEPPT) · NA · recruiting

Other IRCCS San Raffaele trials

Trials by the same sponsor.

NCT07454759 — Acute Sarcopenia in Hospitalized Older Adults · not yet recruiting
NCT07456462 — Making Antibody Treatments More Effective in Early Alzheimer's Disease Using 3Tesla Magnetica Resonance · NA · not yet recruiting
NCT07066878 — This Protocol Focuses on the Factors That Influence Survival, the Development of Complications and the Quality of Life B · not yet recruiting
NCT07526298 — Anticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Ap · not yet recruiting
NCT07426471 — Delafloxacin Plasma and Tissue Concentration in Patients With Skin, Soft Tissue, and Bone and Joint Infections. · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03987334 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by IRCCS San Raffaele
Last refreshed: 23 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03987334.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing